Updated 4-Year Results for NRG Oncology/Rtog 0921: A Phase 2 Study of Postoperative Intensity Modulated Radiation Therapy With Concurrent Cisplatin and Bevacizumab Followed by Carboplatin and Paclitaxel for Patients With Endometrial Cancer
International Journal of Radiation Oncology Biology Physics - Netherlands
doi 10.1016/j.ijrobp.2016.06.130
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2016
Authors
Publisher
Elsevier BV